Jane Street Group, LLC Zai Lab LTD Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$16.25 - $24.14 $3.92 Million - $5.83 Million	241,400 New	241,400 $5.83 Million
Q2 2022 Aug 16, 2022	SELL	$23.14 - $49.68 $485,940 - $1.04 Million	-21,000 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$27.77 - $64.4 $274,923 - $637,560	9,900 Added 89.19%	21,000 $924,000
Q4 2021 Feb 15, 2022	SELL	$54.9 - $105.21 $1.81 Million - $3.47 Million	-33,000 Reduced 74.83%	11,100 $698,000
Q3 2021 Nov 16, 2021	BUY	$105.0 - $178.37 $2.69 Million - $4.57 Million	25,600 Added 138.38%	44,100 $4.65 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $300,264 - $432,000	2,400 Added 14.91%	18,500 $3.27 Million
Q1 2021 May 18, 2021	BUY	$126.27 - $191.71 $2.03 Million - $3.09 Million	16,100 New	16,100 $2.15 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.